Well Told Grants

Federal grant programs / Cancer Research Manpower

Cancer Research Manpower in New Jersey

Cancer Research Manpower (93.398) awarded $8.5 million to recipients in New Jersey in 24 grants from fiscal 2021 to 2025, 0.8% of the program's national total. Rutgers the State University of New Jersey received the most, $6.8 million.

By year

Grants under this program to recipients in New Jersey
Fiscal yearAwardsAmount
FY 20218$1.2 million
FY 202211$1.6 million
FY 202311$2.0 million
FY 202412$2.2 million
FY 20259$1.6 million

Recipients in New Jersey

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
Rutgers the State University of New JerseyColleges and universities12$6.8 million
HMH Hospitals CorporationNonprofits3$737,418
The Trustees of Princeton UniversityColleges and universities4$556,551
Rutgers, the State UniversityColleges and universities2$298,934
Rutgers, the State UniversityColleges and universities2$153,073
Rutgers the State University of New JerseyNonprofits1$64,011

Counted by the recipient's location. A recipient based in New Jersey may carry out the work elsewhere.

Open opportunities under this program

See all 36 on the program page

Questions people ask

How much Cancer Research Manpower money goes to New Jersey?

$8.5 million from fiscal 2021 to 2025, across 24 awards. New Jersey ranks 26th of 45 states and territories for this program.

Who receives Cancer Research Manpower money in New Jersey?

The largest recipient is Rutgers the State University of New Jersey, with $6.8 million in 12 awards. Next are HMH Hospitals Corporation and The Trustees of Princeton University.

Can organizations in New Jersey apply now?

Yes, 36 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Cancer Research Manpower in other states

Other large programs in New Jersey

All federal grants in New Jersey

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.